Shenzhen Noposion Crop Science Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Shenzhen Noposion Crop Science kazanç ve gelirin sırasıyla yıllık 25.1% ve 14.9% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 25.2% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 23.9% olacağı tahmin edilmektedir.

Anahtar bilgiler

25.1%

Kazanç büyüme oranı

25.25%

EPS büyüme oranı

Chemicals kazanç büyümesi	34.6%
Gelir büyüme oranı	14.9%
Gelecekteki özkaynak getirisi	23.91%
Analist kapsamı	Low
Son güncelleme	12 May 2025

Gelecekteki son büyüme güncellemeleri

Recent updates

If EPS Growth Is Important To You, Shenzhen Noposion Crop Science (SZSE:002215) Presents An Opportunity

Feb 26

Shenzhen Noposion Crop Science (SZSE:002215) Might Be Having Difficulty Using Its Capital Effectively

Jan 05

A Piece Of The Puzzle Missing From Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) 26% Share Price Climb

Dec 12

Shenzhen Noposion Crop Science (SZSE:002215) Takes On Some Risk With Its Use Of Debt

Nov 25

We Ran A Stock Scan For Earnings Growth And Shenzhen Noposion Crop Science (SZSE:002215) Passed With Ease

Oct 26

Even With A 26% Surge, Cautious Investors Are Not Rewarding Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) Performance Completely

Sep 24

These 4 Measures Indicate That Shenzhen Noposion Crop Science (SZSE:002215) Is Using Debt Extensively

Aug 20

With EPS Growth And More, Shenzhen Noposion Crop Science (SZSE:002215) Makes An Interesting Case

Jul 19

Estimating The Intrinsic Value Of Shenzhen Noposion Crop Science Co., Ltd. (SZSE:002215)

Apr 02

Investors Still Aren't Entirely Convinced By Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) Earnings Despite 26% Price Jump

Mar 04

Shenzhen Noposion Crop Science (SZSE:002215) Might Be Having Difficulty Using Its Capital Effectively

Feb 27

Kazanç ve Gelir Büyüme Tahminleri

SZSE:002215 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2027	8,634	1,566	N/A	2,033	2
12/31/2026	6,750	1,152	N/A	1,652	3
12/31/2025	6,283	952	N/A	1,108	2
3/31/2025	5,562	757	-141	1,136	N/A
12/31/2024	5,288	585	118	1,306	N/A
9/30/2024	4,955	443	63	1,157	N/A
6/30/2024	4,973	450	314	1,304	N/A
3/31/2024	4,601	472	377	1,329	N/A
12/31/2023	4,120	236	-345	640	N/A
9/30/2023	4,119	307	-524	474	N/A
6/30/2023	4,187	345	-360	695	N/A
3/31/2023	4,337	381	-438	517	N/A
1/1/2023	4,265	328	-730	175	N/A
9/30/2022	4,404	276	-490	394	N/A
6/30/2022	4,522	323	-588	127	N/A
3/31/2022	4,556	323	-576	54	N/A
1/1/2022	4,501	305	-85	422	N/A
9/30/2021	4,112	212	-199	178	N/A
6/30/2021	4,203	197	3	322	N/A
3/31/2021	4,167	184	193	475	N/A
12/31/2020	4,131	167	286	539	N/A
9/30/2020	4,164	259	-125	85	N/A
6/30/2020	4,138	240	-227	21	N/A
3/31/2020	4,141	229	-183	123	N/A
12/31/2019	4,058	236	-116	178	N/A
9/30/2019	4,098	296	354	621	N/A
6/30/2019	4,108	313	316	509	N/A
3/31/2019	4,070	306	194	302	N/A
12/31/2018	4,005	329	N/A	80	N/A
9/30/2018	3,758	354	N/A	-275	N/A
6/30/2018	3,511	359	N/A	-502	N/A
3/31/2018	2,997	355	N/A	-646	N/A
12/31/2017	2,822	309	N/A	-441	N/A
9/30/2017	2,497	214	N/A	-835	N/A
6/30/2017	2,214	-28	N/A	-657	N/A
3/31/2017	2,166	-239	N/A	-341	N/A
12/31/2016	1,963	-276	N/A	-378	N/A
9/30/2016	2,125	-206	N/A	195	N/A
6/30/2016	2,171	-8	N/A	636	N/A
3/31/2016	2,166	225	N/A	755	N/A
12/31/2015	2,210	231	N/A	853	N/A
9/30/2015	2,028	213	N/A	554	N/A
6/30/2015	2,123	215	N/A	239	N/A
3/31/2015	2,258	210	N/A	378	N/A
12/31/2014	2,203	194	N/A	306	N/A
9/30/2014	2,124	188	N/A	239	N/A
6/30/2014	2,045	240	N/A	245	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 002215 'nin tahmini kazanç büyümesi (yıllık 25.1% ) tasarruf oranının ( 2.7% ) üzerindedir.

Kazançlar ve Piyasa: 002215 şirketinin kazançlarının (yıllık 25.1% ) CN pazarından (yıllık 23.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 002215 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: 002215 şirketinin gelirinin (yıllık 14.9% ) CN pazarından (yıllık 12.4% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 002215 şirketinin gelirinin (yıllık 14.9% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 002215 'in Özsermaye Getirisi'nin 3 yıl içinde yüksek olması tahmin ediliyor ( 23.9 %)

Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/06/16 03:45
Gün Sonu Hisse Fiyatı	2025/06/16 00:00
Kazançlar	2025/03/31
Yıllık Kazançlar	2024/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Shenzhen Noposion Crop Science Co., Ltd. 14 Bu analistlerden 3, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Hui Li	China Merchants Securities Co. Ltd.
Xia Sheng	Citic Securities Co., Ltd.
Ruomu Yang	Dongxing Securities Company Limited

Shenzhen Noposion Crop Science Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased by 17% to CN¥15.00

Consensus EPS estimates fall by 10%

Price target increased by 9.8% to CN¥12.27

Price target decreased to CN¥7.76

Recent updates

Dividend increased to CN¥0.35

Investor sentiment improves as stock rises 18%

Shenzhen Noposion Crop Science Co., Ltd. Approves Cash Dividend for 2024

First quarter 2025 earnings released: EPS: CN¥0.64 (vs CN¥0.46 in 1Q 2024)

Shenzhen Noposion Crop Science Co., Ltd., Annual General Meeting, May 16, 2025

Price target increased by 17% to CN¥15.00

Shenzhen Noposion Crop Science Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025

Investor sentiment improves as stock rises 16%

If EPS Growth Is Important To You, Shenzhen Noposion Crop Science (SZSE:002215) Presents An Opportunity

Shenzhen Noposion Crop Science (SZSE:002215) Might Be Having Difficulty Using Its Capital Effectively

Shenzhen Noposion Crop Science Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025

A Piece Of The Puzzle Missing From Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) 26% Share Price Climb

Investor sentiment improves as stock rises 15%

Shenzhen Noposion Crop Science (SZSE:002215) Takes On Some Risk With Its Use Of Debt

Third quarter 2024 earnings released: CN¥0.063 loss per share (vs CN¥0.059 loss in 3Q 2023)

We Ran A Stock Scan For Earnings Growth And Shenzhen Noposion Crop Science (SZSE:002215) Passed With Ease

Shenzhen Noposion Crop Science Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 15%

Even With A 26% Surge, Cautious Investors Are Not Rewarding Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) Performance Completely

Second quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.12 in 2Q 2023)

These 4 Measures Indicate That Shenzhen Noposion Crop Science (SZSE:002215) Is Using Debt Extensively

With EPS Growth And More, Shenzhen Noposion Crop Science (SZSE:002215) Makes An Interesting Case

Shenzhen Noposion Crop Science Co., Ltd. Announces Board Changes

Shenzhen Noposion Crop Science Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Dividend of CN¥0.15 announced

Shenzhen Noposion Crop Science Co., Ltd. Approves Cash Dividend for the Year 2023

New major risk - Financial position

Consensus EPS estimates fall by 10%

Shenzhen Noposion Crop Science Co., Ltd., Annual General Meeting, May 23, 2024

Full year 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.34 in FY 2022)

Estimating The Intrinsic Value Of Shenzhen Noposion Crop Science Co., Ltd. (SZSE:002215)

Shenzhen Noposion Crop Science Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investors Still Aren't Entirely Convinced By Shenzhen Noposion Crop Science Co., Ltd.'s (SZSE:002215) Earnings Despite 26% Price Jump

Now 24% undervalued after recent price drop

Shenzhen Noposion Crop Science (SZSE:002215) Might Be Having Difficulty Using Its Capital Effectively

Investor sentiment deteriorates as stock falls 20%

Now 22% undervalued after recent price drop

Now 21% undervalued

Shenzhen Noposion Crop Science Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

Price target increased by 9.8% to CN¥12.27

Second quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.16 in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.17 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: CN¥0.34 (vs CN¥0.34 in FY 2021)

Investor sentiment improves as stock rises 21%

Price target decreased to CN¥7.76

Insufficient new directors

Insufficient new directors

Third quarter 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.031 profit in 3Q 2021)

Insufficient new directors

Second quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.17 in 2Q 2021)

Shenzhen Noposion Agrochemicals Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2022

Shenzhen Noposion Agrochemicals Co.,Ltd Approves Cash Dividend for 2021

Shenzhen Noposion Agrochemicals Co.,Ltd Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.031 (vs CN¥0.017 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.16 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.14 in 1Q 2020)

Shenzhen Noposion Agrochemicals Co.,Ltd to Report Fiscal Year 2020 Results on Apr 23, 2021

Full year 2020 earnings released: EPS CN¥0.20 (vs CN¥0.26 in FY 2019)

Shenzhen Noposion Agrochemicals Co.,Ltd(XSEC:002215) dropped from S&P Global BMI Index

New 90-day low: CN¥5.19

New 90-day low: CN¥5.65

New 90-day low: CN¥5.85

New 90-day low: CN¥5.87

Third quarter earnings released

Shenzhen Noposion Agrochemicals Co.,Ltd to Report Q3, 2020 Results on Oct 28, 2020

Shenzhen Noposion Agrochemicals Co.,Ltd to Report First Half, 2020 Results on Aug 26, 2020

Shenzhen Noposion Agrochemicals Co.,Ltd (SZSE:002215) agreed to acquire remaining 0.98% in Shaanxi Biaozheng Crop Technology Co., Ltd. from Lu Lihong for CNY 2.2 million.